Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma

Immune checkpoint inhibitors (ICI) have been applied in treating advanced hepatocellular carcinoma (aHCC) patients, but few patients exhibit stable and lasting responses. Moreover, identifying aHCC patients suitable for ICI treatment is still challenged. This study aimed to evaluate whether dissecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jan-Mou, Hung, Yi-Ping, Chou, Kai-Yuan, Lee, Cheng-Yun, Lin, Shian-Ren, Tsai, Ya-Han, Lai, Wan-Yu, Shao, Yu-Yun, Hsu, Chiun, Hsu, Chih-Hung, Chao, Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679144/
https://www.ncbi.nlm.nih.gov/pubmed/36425096
http://dx.doi.org/10.3389/fmed.2022.1008855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679144/
https://www.ncbi.nlm.nih.gov/pubmed/36425096
http://dx.doi.org/10.3389/fmed.2022.1008855

Ejemplares similares